Home Health US approves first new Alzheimer's drug in 20 years

US approves first new Alzheimer’s drug in 20 years

In March 2019, late-stage worldwide trials of aducanumab, involving about 3,000 sufferers, had been halted when evaluation confirmed the drug, given as a month-to-month infusion, was not higher at slowing the deterioration of reminiscence and pondering issues than a dummy drug.

- Advertisment -

Most Popular